{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1361699995469420544.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.1016/j.amjcard.2010.12.012"}},{"identifier":{"@type":"URI","@value":"https://api.elsevier.com/content/article/PII:S0002914910027153?httpAccept=text/xml"}},{"identifier":{"@type":"URI","@value":"https://api.elsevier.com/content/article/PII:S0002914910027153?httpAccept=text/plain"}},{"identifier":{"@type":"PMID","@value":"21349483"}}],"dc:title":[{"@value":"Prevention of Contrast-Induced Nephropathy by Bolus Injection of Sodium Bicarbonate in Patients With Chronic Kidney Disease Undergoing Emergent Coronary Procedures"}],"description":[{"notation":[{"@value":"We conducted a prospective study to determine whether a bolus injection of sodium bicarbonate before emergent coronary procedures in patients with chronic kidney disease (CKD) might prevent contrast-induced nephropathy (CIN). We enrolled 59 patients with CKD, defined by a serum creatinine concentration of1.1 mg/dl or an estimated glomerular filtration rate of60 ml/min, who were scheduled at admission to undergo an emergent coronary procedure. The patients were randomized to receive a bolus intravenous injection of 154 mEq/L of sodium bicarbonate (n = 30) or sodium chloride (n = 29) at the dose of 0.5 ml/kg, before contrast administration, followed by infusion of 154 mEq/L sodium bicarbonate at 1 ml/kg/hour for 6 hours in both groups. The primary end point was the occurrence of CIN, defined as an increase by25% or0.5 mg/dl of the serum creatinine level within 2 days after the procedure. In the sodium bicarbonate group, the serum creatinine concentration remained unchanged within 2 days of contrast administration (from 1.32 ± 0.46 to 1.38 ± 0.60 mg/dl, p = 0.33). In contrast, it had increased in the sodium chloride group (1.51 ± 0.59 to 1.91 ± 1.19 mg/dl, p = 0.006). The incidence of CIN was significantly lower in the sodium bicarbonate group than in the sodium chloride group (3.3% vs 27.6%, p = 0.01). In conclusion, rapid alkalization by bolus injection of sodium bicarbonate was effective for the prevention of CIN in patients with CKD undergoing emergent procedures."}]}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1030291932576823168","@type":"Researcher","personIdentifier":[{"@type":"KAKEN_RESEARCHERS","@value":"30865746"},{"@type":"NRID","@value":"1000030865746"},{"@type":"NRID","@value":"9000020694174"},{"@type":"NRID","@value":"9000248246336"},{"@type":"RESEARCHMAP","@value":"https://researchmap.jp/hiromichiueda"}],"foaf:name":[{"@value":"Hiromichi Ueda"}]},{"@id":"https://cir.nii.ac.jp/crid/1381699995469420549","@type":"Researcher","foaf:name":[{"@value":"Takahisa Yamada"}]},{"@id":"https://cir.nii.ac.jp/crid/1381699995469420546","@type":"Researcher","foaf:name":[{"@value":"Masaharu Masuda"}]},{"@id":"https://cir.nii.ac.jp/crid/1381699995469420556","@type":"Researcher","foaf:name":[{"@value":"Yuji Okuyama"}]},{"@id":"https://cir.nii.ac.jp/crid/1381699995469420545","@type":"Researcher","foaf:name":[{"@value":"Takashi Morita"}]},{"@id":"https://cir.nii.ac.jp/crid/1381699995469420551","@type":"Researcher","foaf:name":[{"@value":"Yoshio Furukawa"}]},{"@id":"https://cir.nii.ac.jp/crid/1381699995469420550","@type":"Researcher","foaf:name":[{"@value":"Tanaka Koji"}]},{"@id":"https://cir.nii.ac.jp/crid/1381699995469420553","@type":"Researcher","foaf:name":[{"@value":"Yusuke Iwasaki"}]},{"@id":"https://cir.nii.ac.jp/crid/1420001326218725504","@type":"Researcher","personIdentifier":[{"@type":"KAKEN_RESEARCHERS","@value":"20750136"},{"@type":"NRID","@value":"1000020750136"},{"@type":"NRID","@value":"9000398280598"},{"@type":"NRID","@value":"9000412546261"},{"@type":"NRID","@value":"9000404528656"},{"@type":"NRID","@value":"9000380977457"},{"@type":"NRID","@value":"9000399380630"},{"@type":"NRID","@value":"9000415348858"},{"@type":"NRID","@value":"9000020694180"},{"@type":"NRID","@value":"9000413571908"},{"@type":"NRID","@value":"9000411567564"},{"@type":"NRID","@value":"9000248246343"},{"@type":"RESEARCHMAP","@value":"https://researchmap.jp/20180402"}],"foaf:name":[{"@value":"Takeshi Okada"}]},{"@id":"https://cir.nii.ac.jp/crid/1381699995469420557","@type":"Researcher","foaf:name":[{"@value":"Masato Kawasaki"}]},{"@id":"https://cir.nii.ac.jp/crid/1410001205226540160","@type":"Researcher","personIdentifier":[{"@type":"NRID","@value":"9000398259627"},{"@type":"NRID","@value":"9000314067574"},{"@type":"NRID","@value":"9000403404965"},{"@type":"NRID","@value":"9000314789393"},{"@type":"NRID","@value":"9000020694137"},{"@type":"NRID","@value":"9000414746288"},{"@type":"NRID","@value":"9000409184170"},{"@type":"NRID","@value":"9000248246345"},{"@type":"RESEARCHMAP","@value":"https://researchmap.jp/krmt_yk"}],"foaf:name":[{"@value":"Yuki Kuramoto"}]},{"@id":"https://cir.nii.ac.jp/crid/1381699995469420554","@type":"Researcher","foaf:name":[{"@value":"Takashi Naito"}]},{"@id":"https://cir.nii.ac.jp/crid/1381699995469420555","@type":"Researcher","foaf:name":[{"@value":"Tadao Fujimoto"}]},{"@id":"https://cir.nii.ac.jp/crid/1381699995469420544","@type":"Researcher","foaf:name":[{"@value":"Issei Komuro"}]},{"@id":"https://cir.nii.ac.jp/crid/1381699995469420547","@type":"Researcher","foaf:name":[{"@value":"Masatake Fukunami"}]}],"publication":{"publicationIdentifier":[{"@type":"PISSN","@value":"00029149"}],"prism:publicationName":[{"@value":"The American Journal of Cardiology"}],"dc:publisher":[{"@value":"Elsevier BV"}],"prism:publicationDate":"2011-04","prism:volume":"107","prism:number":"8","prism:startingPage":"1163","prism:endingPage":"1167"},"reviewed":"false","dc:rights":["https://www.elsevier.com/tdm/userlicense/1.0/"],"url":[{"@id":"https://api.elsevier.com/content/article/PII:S0002914910027153?httpAccept=text/xml"},{"@id":"https://api.elsevier.com/content/article/PII:S0002914910027153?httpAccept=text/plain"}],"createdAt":"2011-02-24","modifiedAt":"2019-06-08","foaf:topic":[{"@id":"https://cir.nii.ac.jp/all?q=Male","dc:title":"Male"},{"@id":"https://cir.nii.ac.jp/all?q=Dose-Response%20Relationship,%20Drug","dc:title":"Dose-Response Relationship, Drug"},{"@id":"https://cir.nii.ac.jp/all?q=Contrast%20Media","dc:title":"Contrast Media"},{"@id":"https://cir.nii.ac.jp/all?q=Coronary%20Angiography","dc:title":"Coronary Angiography"},{"@id":"https://cir.nii.ac.jp/all?q=Sodium%20Bicarbonate","dc:title":"Sodium Bicarbonate"},{"@id":"https://cir.nii.ac.jp/all?q=Treatment%20Outcome","dc:title":"Treatment Outcome"},{"@id":"https://cir.nii.ac.jp/all?q=Injections,%20Intravenous","dc:title":"Injections, Intravenous"},{"@id":"https://cir.nii.ac.jp/all?q=Humans","dc:title":"Humans"},{"@id":"https://cir.nii.ac.jp/all?q=Female","dc:title":"Female"},{"@id":"https://cir.nii.ac.jp/all?q=Prospective%20Studies","dc:title":"Prospective Studies"},{"@id":"https://cir.nii.ac.jp/all?q=Renal%20Insufficiency","dc:title":"Renal Insufficiency"},{"@id":"https://cir.nii.ac.jp/all?q=Acute%20Coronary%20Syndrome","dc:title":"Acute Coronary Syndrome"},{"@id":"https://cir.nii.ac.jp/all?q=Angioplasty,%20Balloon,%20Coronary","dc:title":"Angioplasty, Balloon, Coronary"},{"@id":"https://cir.nii.ac.jp/all?q=Aged","dc:title":"Aged"},{"@id":"https://cir.nii.ac.jp/all?q=Follow-Up%20Studies","dc:title":"Follow-Up Studies"},{"@id":"https://cir.nii.ac.jp/all?q=Glomerular%20Filtration%20Rate","dc:title":"Glomerular Filtration Rate"}],"relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1390282752372831360","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Guideline on the Use of Iodinated Contrast Media in Patients With Kidney Disease 2018"},{"@value":"JCS GUIDELINES : Guideline on the Use of Iodinated Contrast Media in Patients With Kidney Disease 2018"}]},{"@id":"https://cir.nii.ac.jp/crid/1390574666166205056","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Prevention of Contrast-Induced Nephropathy After Cardiovascular Catheterization and Intervention With High-Dose Strong Statin Therapy in Japan　― The PREVENT CINC-J Study ―"}]},{"@id":"https://cir.nii.ac.jp/crid/1390858674102008320","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Prevention of Contrast-Induced Nephropathy After Emergency Percutaneous Coronary Intervention With a Single Bolus Administration of High-Concentrate Sodium Bicarbonate　― Rationale and Design of a Single-Arm Study Compared With Historical Controls ―"}]},{"@id":"https://cir.nii.ac.jp/crid/2050025942143993216","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Guidelines on the use of iodinated contrast media in patients with kidney disease 2012 : digest version"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1016/j.amjcard.2010.12.012"},{"@type":"OPENAIRE","@value":"doi_dedup___::fa490c5545d2d2c840445f7aba611472"},{"@type":"CROSSREF","@value":"10.1253/circj.cj-19-0783_references_DOI_LehOspgiiRtdXJtorUire2hz3n9"},{"@type":"CROSSREF","@value":"10.1253/circrep.cr-22-0105_references_DOI_LehOspgiiRtdXJtorUire2hz3n9"},{"@type":"CROSSREF","@value":"10.1253/circj.cj-21-0869_references_DOI_LehOspgiiRtdXJtorUire2hz3n9"},{"@type":"CROSSREF","@value":"10.1007/s11604-019-00850-2_references_DOI_LehOspgiiRtdXJtorUire2hz3n9"},{"@type":"CROSSREF","@value":"10.1007/s11604-013-0226-4_references_DOI_LehOspgiiRtdXJtorUire2hz3n9"}]}